Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARNO-95: Anastrozole vs Tamoxifen Switch in Breast Cancer
NCT00287534Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 1996
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anastrozole in breast cancer, sponsored by AstraZeneca. Started Nov 1996; status: completed.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00287534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287534.